People with obesity who received the weight-loss drug Zepbound had fewer obstructive sleep apnea events, or episodes of stopped breathing during sleep. The research by drug maker Eli Lilly included ...

June 9 (UPI) A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study reports. Doctors favor treatment with continuous positive ...

Zepbound is the name of the first drug approved by the FDA for obstructive sleep apnea. According to the Mayo Clinic, obstructive sleep apnea is a common sleep-related breathing disorder that occurs ...

Compare the efficacy, benefits, and drawbacks of CPAP therapy and tirzepatide (Zepbound), two of the best treatments for sleep apnea.

That opens the door for broader access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss. Demand for the injection has soared over the last year ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. A popular obesity drug may help treat a ...

Please provide your email address to receive an email when new articles are posted on . NATIONAL HARBOR, Md. — There is a need to identify patients with obstructive sleep apnea after a weight-loss ...

Medically reviewed by Danielle Weiss, MD Zepbound (tirzepatide) and Wegovy (semaglutide) are drugs approved by the Food and Drug Administration (FDA) to treat type 2 diabetes as well as obesity and ...

Compare Zepbound and Wegovy to understand how one hormone vs two impacts weight loss, appetite control, side effects, and ...

Add Yahoo as a preferred source to see more of our stories on Google. Doctors favor treatment with continuous positive airway pressure, or CPAP, machines, researchers are slated to report this week at ...